I

Ipsen Global

Global biopharma focused on specialty care

Director Epidemiology & RWE Sciences

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • An advanced degree in Epidemiology, Public Health, Health Outcomes Research, Pharmacoepidemiology, Biostatistics, Medicine (MD), or a related scientific discipline is required.
  • Extensive biotech or pharmaceutical experience in an Epidemiology, clinical real-world evidence, or outcomes research role within the pharmaceutical, biotech, or healthcare research environment is required.
  • Knowledge of medical, regulatory, and payer systems in one or more regions of the world is required.
  • Demonstrated experience designing and conducting pharmacoepidemiology studies supporting pre- and post-approval evidence generation is required.
  • Demonstrated experience applying innovative methodologies and modern analytical approaches to real-world evidence, ideally in neuroscience or specialty diseases, is required.
  • Expertise in neurosciences, particularly migraine, is a plus.
  • Expertise in data collection methods and strong familiarity with secondary data sources are required.
  • Experience leading external analytical and evidence-generating activities is required.
  • Strong data analytics skills, including knowledge of standard statistical software and packages such as SAS and R, are required.
  • Demonstrated ability to provide strong direct global project management and leadership is required.
  • Exceptional critical thinking to identify gaps, analyze findings, make recommendations, and articulate next steps is required.
  • Fluency in English is required.

Responsibilities

  • Support pre- and post-launch evidence-generating activities across neuroscience products.
  • Lead global evidence strategy and real-world evidence generation for neuroscience assets across the product lifecycle.
  • Provide scientific and strategic leadership to ensure fit-for-purpose real-world evidence supports regulatory, payer, clinical, and medical decision-making, particularly for high-unmet-need neuroscience indications.
  • Define and execute integrated evidence generation plans and oversee real-world evidence studies.
  • Provide methodological epidemiology and real-world evidence leadership and contribute to developing standard operating procedures and guidance documents that promote timely, high-quality, fit-for-purpose evidence generation.
  • Serve as a subject matter expert and build organizational capacity for real-world evidence research.
  • Operate in a global, matrixed environment and ensure evidence generation meets scientific, regulatory, and compliance standards.
  • Partner across the enterprise to support neuroscience evidence needs and design integrated evidence generation plans that address evidence gaps and align with product strategy, disease-area priorities, and the company's integrated data and evidence vision.
  • Provide strategic input to shape evidence addressing regulatory, health technology assessment, payer, clinician, and patient needs.
  • Drive each asset's real-world evidence strategy in partnership with asset teams.
  • Critically review real-world evidence and epidemiology studies designed by external service providers or cross-functional partners for scientific robustness and strategic alignment.
  • Ensure timely, high-quality epidemiology and real-world evidence sections of global regulatory documents, including submissions, risk management plans, breakthrough or orphan designations, and advisory committee briefing books.
  • Support external innovation and business development teams in assessing external licensing opportunities by providing timely disease-population assessments.
  • Partner with clinical development teams to provide epidemiology support for study design and planning.
  • Design prospective and retrospective pharmacoepidemiology studies, including real-world evidence studies, in pre- and post-launch settings and for regulatory post-approval commitments.
  • Develop and adopt robust, fit-for-purpose data-generation and analytical methodologies across lifecycle management stages.
  • Drive adoption of modern real-world evidence methodologies and analytical techniques where conventional approaches may be limited.
  • Apply and champion innovative study designs and modern analytics, including pragmatic approaches, hybrid designs, external control arms, advanced causal-inference methods, and longitudinal disease modeling, as appropriate.
  • Oversee vendor-led and internally led real-world evidence studies, including protocol development, study governance, timelines, quality, and budgets.
  • Ensure methodological rigor while balancing scientific innovation, feasibility, and regulatory acceptability in neurological or rare-disease contexts.
  • Provide budget input for epidemiology and real-world evidence studies and initiatives to ensure adequate resourcing.
  • Ensure real-world evidence activities comply with internal standard operating procedures, global regulations, data privacy requirements, and ethical standards.
  • Participate in reviewing study proposals.
  • Provide consistent support to global and local franchises.
  • Involve internal stakeholders in designing and implementing the real-world evidence framework.
  • Ensure the company can provide comprehensive patient-focused data and analytics in its disease areas.
  • Drive medical, cross-functional, and global alignment to enable early strategic alignment of Medical Affairs.
  • Coordinate epidemiology and real-world evidence studies across global and local teams with Medical Asset Leads, ensuring late-phase data-generation plans maximize data availability, patient impact, and effective execution of real-world evidence programs.

Desired Qualifications

  • A PhD or MD/MPH is strongly preferred.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs